Monday, September 7, 2020

Free Ebook: 3 Options Trades That Work

INO.com

The below offer is brought to you by our associates at DTI Trader

Edward,

Once you get your hands on this simple, yet powerful trading book you will never look at trading the same way again...

In fact, I'm positive you will LOVE trading options...

Because they are one of the best financial instruments ever created to build massive wealth.

You see most people think options are too complex... too risky... and too unreliable to make any sustainable profit.

But this Best-Selling trading author is here to set the record straight with his new ebook.

Inside this book he reveals the 3 trades that will minimize risk and maximize gains using options.

And he is giving it away for FREE. (for a limited time)

Go Here To Download Your Copy

To accept this special invitation, click here.

 
Indexes Snapshot
Symbol Last Change %
Dow Jones Industrial Average 28133.31 -159.42 -0.63%
NASDAQ Composite 11313.14 -144.96 -1.53%
S&P 500 3426.96 -28.10 -0.94%
SPDR S&P 500 342.82 -2.57 -0.85%
iShares Russell 2000 ETF 152.8499 -0.9301 -0.69%
U.S. STOCK INDEXES

The Dow closed lower on Friday as it extended Thursday's sharp decline that marked a key reversal down with today's lower close. A rebound in the afternoon session tempered some of today's losses. The mid-range close sets the stage for a steady to lower opening when Tuesday's night session begins trading. Stochastics and the RSI have turned neutral to bearish signaling that sideways to lower prices are possible near-term. Today's close below the 20-day moving average crossing at 28,144.04 confirms that a short-term top has been posted. If the Dow extends this week's sharp decline, the 50-day moving average crossing at 27,107.74 is the next downside target. If the Dow renews this summer's rally, February's high crossing at 29,568.57 is the next upside target. First resistance is Thursday's high crossing at 29,199.35. Second resistance is February's high crossing at 29,568.57. First support is today's low crossing at 27,664.68. Second support is the 50-day moving average crossing at 27,107.74.

The September NASDAQ 100 closed sharply lower on Friday as it extended the sell off from Wednesday's high. An afternoon rebound tempered some of today's losses and the mid-range close sets the stage for a steady to slightly lower opening when Tuesday's night session begins trading. Closes below the 20-day moving average crossing at 11,602.70 are needed to confirm that a short-term top has been posted. If September resumes the rally off March's low into uncharted territory, upside targets will be hard to project. First resistance is Wednesday's high crossing at 12,465.25. Second resistance is unknown. First support is the 20-day moving average crossing at 11,602.70. Second support is the 50-day moving average crossing at 11,042.12.

The September S&P 500 closed lower on Friday as it extended Thursday's sharp sell off. The low-range close sets the stage for a steady to lower opening when Tuesday's night session begins trading. Stochastics and the RSI are neutral to bearish signaling that sideways to lower prices are possible near-term. Closes below the 20-day moving average crossing at 3427.82 would confirm that a short-term top has been posted. If September renews this year's rally into uncharted territory, upside targets will be hard to project. First resistance is Wednesday's high crossing at 3579.20. Second resistance is unknown. First support is the 20-day moving average crossing at 3427.82. Second support is the 50-day moving average crossing at 3293.68.



Thank you!

Thank you for subscribing to Market Commentary from INO.com.

You can modify your email preferences or unsubscribe here.

INO.com, Inc. | 228 Park Avenue South, Suite 320 | New York, New York 10003

U.S. Government Required Disclaimer - Commodity Futures Trading Commission Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results

These results are based on simulated or hypothetical performance results that have certain inherent limitations. Unlike the results shown in an actual performance record, these results do not represent actual trading. Also, because these trades have not actually been executed, these results may have under-or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity. Simulated or hypothetical trading programs in general are also subject to the fact that they are designed with the benefit of hindsight. No representation is being made that any account will or is likely to achieve profits or losses similar to these being shown.

All trades, patterns, charts, systems, etc., discussed in this message and the product materials are for illustrative purposes only and not to be construed as specific advisory recommendations. All ideas and material presented are entirely those of the author and do not necessarily reflect those of the publisher or INO.com. No system or methodology has ever been developed that can guarantee profits or ensure freedom from losses. No representation or implication is being made that using the methodology or system will generate profits or ensure freedom from losses. The testimonials and examples used herein are exceptional results, which do not apply to the average member, and are not intended to represent or guarantee that anyone will achieve the same or similar results. Each individual's success depends on his or her background, dedication, desire, and motivation.

No comments:

Post a Comment

Skirmish over paper drug info draws on

Delivered every Tuesday and Friday by 12 p.m., Prescription Pulse examines the latest pharmaceutical news and policy...